| Title : Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion - Kalra_2014_Cancer.Res_74_7003 |
| Author(s) : Kalra AV , Kim J , Klinz SG , Paz N , Cain J , Drummond DC , Nielsen UB , Fitzgerald JB |
| Ref : Cancer Research , 74 :7003 , 2014 |
| Abstract : |
| PubMedSearch : Kalra_2014_Cancer.Res_74_7003 |
| PubMedID: 25273092 |
| Title : Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion - Kalra_2014_Cancer.Res_74_7003 |
| Author(s) : Kalra AV , Kim J , Klinz SG , Paz N , Cain J , Drummond DC , Nielsen UB , Fitzgerald JB |
| Ref : Cancer Research , 74 :7003 , 2014 |
| Abstract : |
| PubMedSearch : Kalra_2014_Cancer.Res_74_7003 |
| PubMedID: 25273092 |
| Title : Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion - Kalra_2014_Cancer.Res_74_7003 |
| Author(s) : Kalra AV , Kim J , Klinz SG , Paz N , Cain J , Drummond DC , Nielsen UB , Fitzgerald JB |
| Ref : Cancer Research , 74 :7003 , 2014 |
| Abstract : |
| PubMedSearch : Kalra_2014_Cancer.Res_74_7003 |
| PubMedID: 25273092 |